Effectiveness of manual therapy interventions in cystic fibrosis care: a pilot study.
Cystic fibrosis
Lung function
Manual therapies
Muscle strength
Musculoskeletal manipulation
Pain
Physiotherapy
Journal
Journal of bodywork and movement therapies
ISSN: 1532-9283
Titre abrégé: J Bodyw Mov Ther
Pays: United States
ID NLM: 9700068
Informations de publication
Date de publication:
Jul 2024
Jul 2024
Historique:
received:
03
08
2023
revised:
22
01
2024
accepted:
25
02
2024
medline:
15
6
2024
pubmed:
15
6
2024
entrez:
14
6
2024
Statut:
ppublish
Résumé
Cystic fibrosis (CF) is a severe genetic condition that affects multiple organ systems and imposes a substantial treatment burden. Regarding the lungs and airways, the progressive pathophysiological changes place a significant strain on the musculoskeletal components of the respiratory system for people with CF. This pilot study investigated the effectiveness of manual therapy interventions (MTIs) on thoracic mobility, respiratory muscle strength, lung function, and musculoskeletal pain. A study with a pretest-posttest design was conducted with 15 eligible people with CF at the Sahlgrenska University Hospital CF Centre. After an initial set of diagnostic tests at baseline, the participants underwent eight weekly 30-min MTIs. The MTIs included passive joint mobilisation and soft tissue manipulation of primary and secondary anatomical areas of the musculoskeletal respiratory system. On the day of the final intervention, the baseline measurements were repeated. Trends of increased thoracic mobility were observed following the intervention, with a statistically significant increase in respiratory muscle strength. No change in lung function was observed. Musculoskeletal pain before and after the intervention showed a significant decrease in tender points, and all participants reported positive experiences with MTIs. MTIs may improve thoracic mobility, alleviate pain, and enhance respiratory muscle strength in people with CF. Further research is needed to confirm their potential role as a CF physiotherapy supplement. NCT04696198.
Sections du résumé
BACKGROUND
BACKGROUND
Cystic fibrosis (CF) is a severe genetic condition that affects multiple organ systems and imposes a substantial treatment burden. Regarding the lungs and airways, the progressive pathophysiological changes place a significant strain on the musculoskeletal components of the respiratory system for people with CF. This pilot study investigated the effectiveness of manual therapy interventions (MTIs) on thoracic mobility, respiratory muscle strength, lung function, and musculoskeletal pain.
METHOD
METHODS
A study with a pretest-posttest design was conducted with 15 eligible people with CF at the Sahlgrenska University Hospital CF Centre. After an initial set of diagnostic tests at baseline, the participants underwent eight weekly 30-min MTIs. The MTIs included passive joint mobilisation and soft tissue manipulation of primary and secondary anatomical areas of the musculoskeletal respiratory system. On the day of the final intervention, the baseline measurements were repeated.
RESULTS
RESULTS
Trends of increased thoracic mobility were observed following the intervention, with a statistically significant increase in respiratory muscle strength. No change in lung function was observed. Musculoskeletal pain before and after the intervention showed a significant decrease in tender points, and all participants reported positive experiences with MTIs.
CONCLUSION
CONCLUSIONS
MTIs may improve thoracic mobility, alleviate pain, and enhance respiratory muscle strength in people with CF. Further research is needed to confirm their potential role as a CF physiotherapy supplement.
CLINICAL TRIAL ID
BACKGROUND
NCT04696198.
Identifiants
pubmed: 38876647
pii: S1360-8592(24)00093-7
doi: 10.1016/j.jbmt.2024.02.036
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT04696198']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
323-329Informations de copyright
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing interest None